35Pharma
Company Information
35Pharma is a Montreal-based biopharmaceutical company developing ligand traps that target Activin and GDF biology. Its lead program, HS235, is being developed for pulmonary hypertension and cardiometabolic disease, with additional focus areas in heart failure and obesity. The company positions its platform around multi-specific, protein-engineered biologics designed for high unmet-need indications.
Industry Focus and Technologies
Biologics, protein engineering, ligand traps, cardiometabolic disease, pulmonary hypertension, heart failure, and obesity therapeutics.
Location
Montreal, Quebec, Canada
Company Size and Stage
Products, Platforms or Focus Areas
Activin x GDF ligand traps; HS235; protein-engineered biologics; biomarker-informed clinical development for pulmonary hypertension, heart failure, obesity, and cardiometabolic disease.